About IXA
Innovation Exchange Amsterdam (IXA) is the expert interface between Amsterdam-based universities and parties interested in their research findings and knowledge, such as companies, educational institutions, investors, health care providers, entrepreneurs, government bodies and societal organisations. Being an interface, IXA deploys its expertise in both directions: assisting researchers in generating societal and economic impact from their work and assisting external parties in navigating the academic landscape to find a solution or spot an opportunity.
IXA is a collaboration between the Knowledge Transfer Offices of:
- Amsterdam University Medical Centre
- Amsterdam University of Applied Sciences/ Hogeschool van Amsterdam
- University of Amsterdam
- Vrije Universiteit Amsterdam
Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
News
2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
News
Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
News